OH

Ohad Hammer

Partner at Pontifax Venture Capital

Israel

Investor
VC
Scout

Invests in

Stages:

Series A
Seed

Locations:

Israel

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Biotechnology
Lifesciences
Immunology
R&D
Cancer
Antibodies
Drug Development
Clinical Trials
Biopharmaceuticals
Monoclonal Antibodies
Pharmaceutical Industry
Cancer Research
Technology Transfer
Start-ups
Life Sciences

Education

Lists including Ohad

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

Adcytherix

Seed

Total Funding: $32M

Eliem Therapeutics

Post Ipo Equity

Total Funding: $380M

AgomAb Therapeutics

Series A

Total Funding: $200M

ADCendo

Series A

Total Funding: $110M

Anaveon

Series B

Total Funding: $160M

Emergence Therapeutics

Series A

Total Funding: $98M

Step Pharma

Series A

Total Funding: $61M

Amolyt Pharma

Series A

Total Funding: $290M

Precirix

Series A

Total Funding: $130M

Coave Therapeutics

Series B

Total Funding: $22M

Work Experience

PV
Pontifax Venture Capital

2015

  • Partner

    2015

Pontifax

2009 - 2015

  • Analyst

    2009 - 2015

    http://www.pontifax.com/

TU
Tel-Aviv University

2005 - 2007

  • researcher

    2005 - 2007